Faculty profile
Housheng He
Back to facultyResearch
Read how they describe their research on their University of Toronto profile.
Latest funding
- $1,147,500
Unlocking the Role of RNA Modifications in Prostate Cancer
CIHR · 2026 · Nominated PI
- $1,147,500
The N6-methyladenosine Epitranscriptome and Functional Landscape of Lung Adenocarcinoma
CIHR · 2025 · Nominated PI
- $105,000
Deciphering the pan-cancer functional landscape of circular RNAs in primary versus acquired resistance to immunotherapy for precision oncology
CIHR · 2023 · Supervisor
No publications available.
Unlocking the Role of RNA Modifications in Prostate Cancer
Principal investigators: He, Housheng H
Keywords: M6a Rna Modification; Prostate Cancer
The N6-methyladenosine Epitranscriptome and Functional Landscape of Lung Adenocarcinoma
Principal investigators: He, Housheng H; Tsao, Ming-Sound
Keywords: M6a Rna Modification
Deciphering the pan-cancer functional landscape of circular RNAs in primary versus acquired resistance to immunotherapy for precision oncology
Principal investigators: Her, Peter
Keywords: Bioinformatics; Biomarker Discovery; Cancer Biology; Circular Rna; Genomics; Immuno-Oncology; Immunotherapy Resistance; Machine Learning; Noncoding Rna; Transcriptomics
Canada Research Chair - Tier 1
Principal investigators: He, Housheng H
Keywords: Crc
Charting the dedifferentiation roadmap of pancreatic neuroendocrine tumours
Principal investigators: Michael, Iacovos P
Keywords: Cancer Cell Plasticity; Dedifferentiation; Hmgb3; Mir-181; Pancreatic Neuroendocrine Tumors
Function of LSD1 in aggressive prostate cancer
Principal investigators: He, Housheng H
Keywords: Epigenetic Regulation; Histone Modification; Lsd1; Prostate Cancer
In vivo CRISPR screen to identify clinically relevant therapeutic targets for lung cancer
Principal investigators: Schramek, Daniel
Keywords: Cancer Research; Crispr/Cas9 Screening; Drug Target Discovery; Functional Genomics; Molecular Biology
Express delivery of RNA therapeutics to cancer
Principal investigators: Zheng, Gang
Discovering druggable targets in advanced prostate cancer with in vivo CRISPR screens
Principal investigators: Xue, Yibo
Keywords: Cancer Biology; Crispr; Druggable Targets; Genetic Screen; Patient Derived Xenografts; Prostate Cancer
Alternatively and trans-spliced isoforms as a new class of biomarkers of response to cytotoxic and targeted therapies in metastatic triple-negative breast cancer
Principal investigators: Haibe-Kains, Benjamin
Keywords: Breast Cancer
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.
Profile data last refreshed on September 25, 2026 from the university directory, publication records and CIHR, NSERC and SSHRC funding.